| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical-stage biotechnology company focused on the discovery and development of ...
HC Wainwright & Co. analyst Joseph Pantginis maintains Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy and raises the pr...